Literature DB >> 28963115

The Bone Marrow Microenvironment in Health and Myeloid Malignancy.

Marta Galán-Díez1, Álvaro Cuesta-Domínguez1, Stavroula Kousteni1.   

Abstract

Hematopoietic stem cells (HSCs) interact dynamically with an intricate network of cells in the bone marrow (BM) microenvironment or niche. These interactions provide instructive cues that influence the production and lineage determination of different types of blood cells and maintenance of HSC quiescence. They also contribute to hematopoietic deregulation and hematological myeloid malignancies. Alterations in the BM niche are commonly observed in myeloid malignancies and contribute to the aberrant function of myelodysplastic and leukemia-initiating stem cells. In this work, we review how different components of the BM niche affect normal hematopoiesis, the molecular signals that govern this interaction, and how genetic changes in stromal cells or alterations in remodeled malignant BM niches contribute to myeloid malignancies. Understanding the intricacies between normal and malignant niches and their modulation may provide insights into developing novel therapeutics for blood disorders.
Copyright © 2018 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28963115      PMCID: PMC6027930          DOI: 10.1101/cshperspect.a031328

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  131 in total

Review 1.  Notch as a mediator of cell fate determination in hematopoiesis: evidence and speculation.

Authors:  L A Milner; A Bigas
Journal:  Blood       Date:  1999-04-15       Impact factor: 22.113

2.  The myelopoietic supportive capacity of mesenchymal stromal cells is uncoupled from multipotency and is influenced by lineage determination and interference with glycosylation.

Authors:  Vered Morad; Meirav Pevsner-Fischer; Sivan Barnees; Albena Samokovlisky; Liat Rousso-Noori; Rakefet Rosenfeld; Dov Zipori
Journal:  Stem Cells       Date:  2008-06-12       Impact factor: 6.277

3.  The relationship between bone, hemopoietic stem cells, and vasculature.

Authors:  Sarah L Ellis; Jochen Grassinger; Allan Jones; Judy Borg; Todd Camenisch; David Haylock; Ivan Bertoncello; Susan K Nilsson
Journal:  Blood       Date:  2011-06-14       Impact factor: 22.113

4.  Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells.

Authors:  Susan K Nilsson; Hayley M Johnston; Genevieve A Whitty; Brenda Williams; Ryan J Webb; David T Denhardt; Ivan Bertoncello; Linda J Bendall; Paul J Simmons; David N Haylock
Journal:  Blood       Date:  2005-04-21       Impact factor: 22.113

5.  Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region.

Authors:  Fumihiko Ishikawa; Shuro Yoshida; Yoriko Saito; Atsushi Hijikata; Hiroshi Kitamura; Satoshi Tanaka; Ryu Nakamura; Toru Tanaka; Hiroko Tomiyama; Noriyuki Saito; Mitsuhiro Fukata; Toshihiro Miyamoto; Bonnie Lyons; Koichi Ohshima; Naoyuki Uchida; Shuichi Taniguchi; Osamu Ohara; Koichi Akashi; Mine Harada; Leonard D Shultz
Journal:  Nat Biotechnol       Date:  2007-10-21       Impact factor: 54.908

6.  BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells.

Authors:  Eleni D Lagadinou; Alexander Sach; Kevin Callahan; Randall M Rossi; Sarah J Neering; Mohammad Minhajuddin; John M Ashton; Shanshan Pei; Valerie Grose; Kristen M O'Dwyer; Jane L Liesveld; Paul S Brookes; Michael W Becker; Craig T Jordan
Journal:  Cell Stem Cell       Date:  2013-01-17       Impact factor: 24.633

7.  Osteoblastic cells regulate the haematopoietic stem cell niche.

Authors:  L M Calvi; G B Adams; K W Weibrecht; J M Weber; D P Olson; M C Knight; R P Martin; E Schipani; P Divieti; F R Bringhurst; L A Milner; H M Kronenberg; D T Scadden
Journal:  Nature       Date:  2003-10-23       Impact factor: 49.962

8.  Purification and characterization of mouse hematopoietic stem cells.

Authors:  G J Spangrude; S Heimfeld; I L Weissman
Journal:  Science       Date:  1988-07-01       Impact factor: 47.728

9.  Mesenchymal stromal cells derived from acute myeloid leukemia bone marrow exhibit aberrant cytogenetics and cytokine elaboration.

Authors:  J C Huang; S K Basu; X Zhao; S Chien; M Fang; V G Oehler; F R Appelbaum; P S Becker
Journal:  Blood Cancer J       Date:  2015-04-10       Impact factor: 11.037

10.  Massive parallel RNA sequencing of highly purified mesenchymal elements in low-risk MDS reveals tissue-context-dependent activation of inflammatory programs.

Authors:  S Chen; N A Zambetti; E M J Bindels; K Kenswill; A M Mylona; N M Adisty; R M Hoogenboezem; M A Sanders; E M P Cremers; T M Westers; J H Jansen; A A van de Loosdrecht; M H G P Raaijmakers
Journal:  Leukemia       Date:  2016-04-25       Impact factor: 11.528

View more
  13 in total

Review 1.  Regulation of Energy Metabolism by Bone-Derived Hormones.

Authors:  Paula Mera; Mathieu Ferron; Ioanna Mosialou
Journal:  Cold Spring Harb Perspect Med       Date:  2018-06-01       Impact factor: 6.915

Review 2.  In Vitro and In Vivo Modeling of Normal and Leukemic Bone Marrow Niches: Cellular Senescence Contribution to Leukemia Induction and Progression.

Authors:  Myriam Janeth Salazar-Terreros; Jean-Paul Vernot
Journal:  Int J Mol Sci       Date:  2022-07-01       Impact factor: 6.208

Review 3.  Microenvironmental Features Driving Immune Evasion in Myelodysplastic Syndromes and Acute Myeloid Leukemia.

Authors:  Georgios Petros Barakos; Eleftheria Hatzimichael
Journal:  Diseases       Date:  2022-06-10

4.  Transient expansion and myofibroblast conversion of adipogenic lineage precursors mediate bone marrow repair after radiation.

Authors:  Leilei Zhong; Lutian Yao; Nicholas Holdreith; Wei Yu; Tao Gui; Zhen Miao; Yehuda Elkaim; Mingyao Li; Yanqing Gong; Maurizio Pacifici; Amit Maity; Theresa M Busch; Kyu Sang Joeng; Keith Cengel; Patrick Seale; Wei Tong; Ling Qin
Journal:  JCI Insight       Date:  2022-04-08

5.  Subversion of Serotonin Receptor Signaling in Osteoblasts by Kynurenine Drives Acute Myeloid Leukemia.

Authors:  Marta Galán-Díez; Florence Borot; Abdullah Mahmood Ali; Junfei Zhao; Eva Gil-Iturbe; Xiaochuan Shan; Na Luo; Yongfeng Liu; Xi-Ping Huang; Brygida Bisikirska; Rossella Labella; Irwin Kurland; Bryan L Roth; Matthias Quick; Siddhartha Mukherjee; Raul Rabadán; Martin Carroll; Azra Raza; Stavroula Kousteni
Journal:  Cancer Discov       Date:  2022-04-01       Impact factor: 38.272

Review 6.  Cadherins, Selectins, and Integrins in CAM-DR in Leukemia.

Authors:  Hye Na Kim; Yongsheng Ruan; Heather Ogana; Yong-Mi Kim
Journal:  Front Oncol       Date:  2020-12-10       Impact factor: 6.244

Review 7.  Natural Killer Cells in the Malignant Niche of Multiple Myeloma.

Authors:  Ondrej Venglar; Julio Rodriguez Bago; Benjamin Motais; Roman Hajek; Tomas Jelinek
Journal:  Front Immunol       Date:  2022-01-11       Impact factor: 7.561

Review 8.  CAM-DR: Mechanisms, Roles and Clinical Application in Tumors.

Authors:  Yuejiao Huang; Yuchan Wang; Jie Tang; Shiyi Qin; Xianjuan Shen; Song He; Shaoqing Ju
Journal:  Front Cell Dev Biol       Date:  2021-07-06

Review 9.  In Vitro Modeling of Non-Solid Tumors: How Far Can Tissue Engineering Go?

Authors:  Sandra Clara-Trujillo; Gloria Gallego Ferrer; José Luis Gómez Ribelles
Journal:  Int J Mol Sci       Date:  2020-08-11       Impact factor: 5.923

10.  CSF-1R inhibition disrupts the dialog between leukaemia cells and macrophages and delays leukaemia progression.

Authors:  Kun Li; Wenfu Xu; Ke Lu; Yuxi Wen; Tianqing Xin; Yaqing Shen; Xueyan Lv; Shimin Hu; Runming Jin; Xiaoyan Wu
Journal:  J Cell Mol Med       Date:  2020-10-10       Impact factor: 5.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.